Honasa Consumer targets Rs 5,550 crore revenue and 15% EBITDA margin by FY31

Mamaearth parent Honasa Consumer is targeting Rs 5,550 crore in revenue by FY31, alongside a 15% EBITDA margin. The company plans to build growth around its core beauty and baby-care businesses, which contribute about 80% of revenue, while expanding into new consumer segments.

— Source publishedFri, 4 Sept, 2026, 18:10 IST·First seen Fri, 4 Sept, 2026, 18:46 IST·Source NDTV Profit

What happened

Mamaearth parent Honasa Consumer targets Rs 5,550 crore revenue and 15% EBITDA margin by FY31. Growth will focus on core beauty and baby-care categories, while

Key facts

  • Rs 5,550 crore revenue target by FY31
  • Rs 5,000 crore Indian FMCG revenue milestone
  • 15% EBITDA margin target by FY31
  • 500 basis points potential EBITDA-margin expansion
  • FY26 total income of Rs 475.53 crore
  • 15.37% year-on-year growth in FY26
  • Core categories contribute about 80% of revenue

Why this matters

Honasa’s emphasis on adjacent consumer segments signals potential partnership, acquisition and brand-launch opportunities that can extend its beauty and baby-care platform without diluting core economics.

What to watch

  • Quarterly revenue growth in the core beauty and baby-care portfolio versus total company growth.
  • EBITDA-margin progression, especially whether advertising and promotion expense declines as a percentage of sales.
  • Offline channel contribution, store reach, same-channel sell-through and inventory days.
  • Repeat-purchase rates, cohort retention and the share of sales from existing customers.
  • Mix shift toward premium skincare, derma, personal care and higher-margin formats.
  • New-category contribution versus the growth rate of established brands.
  • Gross-margin movement amid packaging, commodity and trade-promotion costs.
  • Competitive activity from large FMCG beauty players, specialist skincare brands and D2C challengers.
  • Prioritize distribution density and shelf visibility for core beauty and baby-care brands before materially widening the portfolio.
  • Shift marketing toward retention, creator-led advocacy and CRM to reduce dependence on paid digital acquisition.
  • Increase premium and science-led skincare mix, particularly through The Derma Co. and differentiated problem-solution products, to support gross margin.
  • Expand general-trade and modern-trade coverage with tighter inventory controls to limit channel stuffing and elevated returns.
  • Rationalize slower SKUs and concentrate innovation spending on categories with demonstrable repeat purchase and cross-sell potential.
  • Use scale in packaging, ingredients and manufacturing to protect gross margin against promotional intensity and input-cost volatility.